Namzaric (memantine HCl extended release and donepezil HCl) capsules 14 mg/10 mg per capsule 30 c...
FDA Recall #D-0418-2021 — Class II — March 15, 2021
Product Description
Namzaric (memantine HCl extended release and donepezil HCl) capsules 14 mg/10 mg per capsule 30 capsules Rx Only NDC 0456-1214-30 Distributed by Forest Pharmaceuticals, Inc. Subsidiary of Forest Laboratories, LLC.
Reason for Recall
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Recalling Firm
Cardinal Health Inc. — Dublin, OH
Classification
Class II — May cause temporary or medically reversible adverse health consequences.
Product Type
Drugs
Product Quantity
659 bottles
Distribution
FL, GA, SC
Code Information
W04815
Status
Terminated
Voluntary / Mandated
Voluntary: Firm initiated
What Should You Do?
Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.